Jan C. Roos

5.7k total citations
108 papers, 4.5k citations indexed

About

Jan C. Roos is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Orthopedics and Sports Medicine. According to data from OpenAlex, Jan C. Roos has authored 108 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Radiology, Nuclear Medicine and Imaging, 27 papers in Pulmonary and Respiratory Medicine and 24 papers in Orthopedics and Sports Medicine. Recurrent topics in Jan C. Roos's work include Radiopharmaceutical Chemistry and Applications (30 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and Bone health and osteoporosis research (22 papers). Jan C. Roos is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (30 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and Bone health and osteoporosis research (22 papers). Jan C. Roos collaborates with scholars based in Netherlands, United States and United Kingdom. Jan C. Roos's co-authors include Paul Lips, E. J. Dorhout Mees, L.M. Bouter, P.D. Bezemer, C. Popp‐Snijders, Marius Ooms, Peter de Boer, Guus A.M.S. van Dongen, Warwick F. Vincent and W J van der Vijgh and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Jan C. Roos

107 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan C. Roos Netherlands	38	1.2k	811	801	775	774	108	4.5k
Brian C. Lentle Canada	32	1.7k 1.5×	601 0.7×	352 0.4×	803 1.0×	497 0.6×	139	3.6k
Lene Heickendorff Denmark	51	1.0k 0.9×	1.1k 1.3×	324 0.4×	1.2k 1.5×	2.0k 2.6×	158	6.7k
P.D. Delmas France	32	2.6k 2.2×	1.5k 1.8×	325 0.4×	1.7k 2.2×	930 1.2×	56	5.5k
O. L. M. Bijvoet Netherlands	34	1.4k 1.2×	1.1k 1.3×	508 0.6×	2.8k 3.6×	375 0.5×	86	4.6k
Jenifer Jowsey United States	43	1.8k 1.5×	1.0k 1.3×	236 0.3×	1.2k 1.6×	673 0.9×	150	5.1k
Davide Gatti Italy	49	3.0k 2.6×	1.6k 1.9×	265 0.3×	2.0k 2.6×	1.2k 1.6×	283	7.4k
M. K. Drezner United States	25	2.2k 1.9×	1.7k 2.2×	173 0.2×	1.4k 1.9×	1.5k 1.9×	45	5.7k
Lars Melholt Rasmussen Denmark	47	596 0.5×	2.9k 3.6×	353 0.4×	892 1.2×	486 0.6×	288	8.2k
Ombretta Viapiana Italy	38	1.6k 1.3×	990 1.2×	171 0.2×	1.0k 1.3×	762 1.0×	234	4.6k
D. Sudhaker Rao United States	29	2.9k 2.5×	1.2k 1.4×	253 0.3×	1.7k 2.2×	1.0k 1.3×	45	4.6k

Countries citing papers authored by Jan C. Roos

Since Specialization

Citations

This map shows the geographic impact of Jan C. Roos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan C. Roos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan C. Roos more than expected).

Fields of papers citing papers by Jan C. Roos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan C. Roos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan C. Roos. The network helps show where Jan C. Roos may publish in the future.

Co-authorship network of co-authors of Jan C. Roos

This figure shows the co-authorship network connecting the top 25 collaborators of Jan C. Roos. A scholar is included among the top collaborators of Jan C. Roos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan C. Roos. Jan C. Roos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pluijm, Saskia M.F., M.L. te Winkel, Hester A. de Groot‐Kruseman, et al.. (2015). Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia. Haematologica. 100(12). 1564–1570. 20 indexed citations

Bodegraven, Adriaan A. van, Nathalie Bravenboer, Birgit I. Lissenberg‐Witte, et al.. (2013). Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation. Gut. 63(9). 1424–1430. 18 indexed citations

Bakker, Sjoerd F., Vincent K. Dik, Birgit I. Lissenberg‐Witte, et al.. (2012). Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation. Journal of Crohn s and Colitis. 7(5). 377–384. 24 indexed citations

Dijk, Christel E. van, et al.. (2008). Positive association between the course of vitamin D intake and bone mineral density at 36 years in men. Bone. 44(3). 437–441. 3 indexed citations

Laken, Conny J. van der, Alexandre E. Voskuyl, Jan C. Roos, et al.. (2006). Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(2). 253–256. 147 indexed citations

Tromp, A. M., Nathalie Bravenboer, Esther Tanck, et al.. (2006). Additional Weight Bearing during Exercise and Estrogen in the Rat: The Effect on Bone Mass, Turnover, and Structure. Calcified Tissue International. 79(6). 404–415. 46 indexed citations

Arwert, Lucia I., Jan C. Roos, Paul Lips, et al.. (2005). Effects of 10 years of growth hormone (GH) replacement therapy in adult GH‐deficient men. Clinical Endocrinology. 63(3). 310–316. 44 indexed citations

Börjesson, Pontus K.E., Ernst J. Postema, Remco de Bree, et al.. (2004). Radioimmunodetection and radioimmunotherapy of head and neck cancer. Oral Oncology. 40(8). 761–772. 23 indexed citations

Colnot, David R., Jan C. Roos, Remco de Bree, et al.. (2003). Safety, biodistribution, pharmacokinetics, and immunogenicity of 99m Tc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck. Cancer Immunology Immunotherapy. 52(9). 576–582. 52 indexed citations

10.

Neele, Simone J.M., et al.. (2002). Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women. Bone. 30(4). 599–603. 75 indexed citations

11.

Temmerman, Olivier P.P., et al.. (2001). Detection of osteomyelitis using 18FDG and positron emission tomography. The Journal of Arthroplasty. 16(2). 243–246. 12 indexed citations

12.

Colnot, David R., Jasper J. Quak, Jan C. Roos, et al.. (2001). Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience. Head & Neck. 23(7). 559–565. 11 indexed citations

13.

Kemper, Han C. G., Jos W. R. Twisk, Willem van Mechelen, et al.. (2000). A fifteen-year longitudinal study in young adults on the relation of physical activity and fitness with the development of the bone mass: the Amsterdam Growth and Health Longitudinal Study. Bone. 27(6). 847–853. 111 indexed citations

14.

Patka, P., et al.. (1999). Long-term consequences of fracture of the lower leg: cross-sectional study and long-term longitudinal follow-up of bone mineral density in the hip after fracture of lower leg. Bone. 24(2). 131–134. 38 indexed citations

15.

Bree, Remco de, Dirk J. Kuik, Jasper J. Quak, et al.. (1998). The impact of tumour volume and other characteristics on uptake of radiolabelled monoclonal antibodies in tumour tissue of head and neck cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 25(11). 1562–1565. 19 indexed citations

16.

Molthoff, Carla F.M., Peter Kenemans, Jan C. Roos, et al.. (1998). Biodistribution of 111 In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01. Cancer Immunology Immunotherapy. 47(1). 39–46. 16 indexed citations

17.

Lingen, Arthur van, et al.. (1996). Absorbed dose distribution of the auger emitters 67Ga and 125I and the β-emitters 67Cu, 90Y, 131I, and 186Re as a function of tumor size, uptake, and intracellular distribution. International Journal of Radiation Oncology*Biology*Physics. 36(1). 197–204. 13 indexed citations

18.

Roos, Jan C., et al.. (1994). Comparison of non-invasive approaches to red marrow dosimetry for radiolabelled monoclonal antibodies. European Journal of Nuclear Medicine and Molecular Imaging. 21(3). 216–222. 12 indexed citations

19.

Cock, Carel C. de, et al.. (1992). Prognostic Value of Thallium-201 Exercise Scintigraphy in Low-Risk Patients after Q-Wave Myocardial Infarction: Comparison with Exercise Testing and Catheterization. Cardiology. 81(6). 342–350. 3 indexed citations

20.

Roos, Jan C., et al.. (1982). Changes in Intrarenal Uric Acid Handling during Chronic Spironolactone Treatment in Patients with Essential Hypertension. The Nephron journals/Nephron journals. 32(3). 209–213. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact